文献速递咽喉与嗓音头颈外科

异型增生声带病变的恶性转化:系统综述与Meta分析

Malignant Transformation of Dysplastic Vocal Fold Lesions: A Systematic Review and Meta-Analysis.
PubMed 文献 · JAMA Otolaryngol Head Neck Surg · 2024-01-01

该系统综述与Meta分析检索多个数据库至2023年6月8日,纳入18项回顾性队列研究共3243例患者,评估基于2005年WHO异型增生分类的喉异型增生病变恶性转化率及时间。轻度、中度、重度异型增生加权汇总恶性转化率分别为10.9%、23.3%、30.5%,无异型增生病变为4.5%;全部异型增生等级总体平均转化时间为28.8个月。

要点

  • 轻度、中度、重度异型增生恶性转化率分别为10.9%、23.3%、30.5%,无异型增生为4.5%。
  • 中度与重度异型增生恶性转化风险显著高于轻度,OR分别为2.90与3.42。
  • 全部异型增生等级总体平均恶性转化时间为28.8个月(范围22.0-35.6个月)。

核心结论

  • 喉异型增生恶性转化率随异型增生等级升高而增加,中度异型增生较轻度更易发生恶性转化。

研究设计与样本

  • 系统综述与Meta分析,检索PubMed、MEDLINE、Embase、CINAHL、CENTRAL及Cochrane Reviews自建库至2023年6月8日的文献。
  • 纳入18项回顾性队列研究,共3243例参与者,使用2005年WHO异型增生分类系统评估恶性转化率。
  • 数据由2名独立研究者提取,研究质量采用经验证的质量工具评估,尽可能使用随机效应Meta分析合并数据。

主要发现

  • 轻度、中度、重度异型增生病变加权汇总平均恶性转化率分别为10.9%、23.3%、30.5%,无异型增生喉病变为4.5%。
  • 中度异型增生较轻度恶性转化风险显著升高(OR 2.90,95%CI 2.06-4.09;I²=0%)。
  • 重度异型增生较轻度恶性转化风险显著升高(OR 3.42,95%CI 2.11-5.52;I²=40%)。
  • 无异型增生病变较轻度异型增生恶性转化风险显著降低(OR 0.48,95%CI 0.28-0.81;I²=0%)。
  • 全部异型增生等级总体平均恶性转化时间为28.8个月(范围22.0-35.6个月)。

关键数值与推荐

  • 轻度异型增生加权汇总恶性转化率为10.9%。
  • 中度异型增生加权汇总恶性转化率为23.3%。
  • 重度异型增生加权汇总恶性转化率为30.5%。
  • 无异型增生喉病变恶性转化率为4.5%。
  • 全部异型增生等级总体平均恶性转化时间为28.8个月(范围22.0-35.6个月)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 纳入研究均为回顾性队列研究。
  • 原文未报告其他局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: The reported rates of malignant transformation of dysplastic laryngeal lesions are highly variable, as is time to malignant degeneration. OBJECTIVE: To evaluate the rate of and time to malignant transformation of dysplastic laryngeal lesions based on the World Health Organization (WHO) dysplasia classification system. DATA SOURCES: PubMed, MEDLINE, Embase, CINAHL, CENTRAL, and Cochrane Reviews were searched from the date of database inception to June 8, 2023. STUDY SELECTION: English-language articles assessing the rate of malignant transformation using the 2005 WHO dysplasia classification system were included in this systematic review and meta-analysis. DATA EXTRACTION AND SYNTHESIS: The study was reported in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-analyses (PRISMA) reporting guideline. Data extraction was performed by 2 independent investigators. Study quality was assessed using a validated quality tool. When possible, data were pooled using random-effects meta-analysis. MAIN OUTCOME MEASURES: The primary outcome measure was the malignant transformation rate in each laryngeal dysplasia category. Secondary outcome measure was the time interval over which malignant transformation had occurred. RESULTS: A total of 5585 records were screened, 61 full texts were assessed, and 18 retrospective cohort studies with 3243 participants were included in the final review. The weighted pooled mean malignant transformation rates of mildly, moderately, and severely dysplastic lesions were 10.9%, 23.3%, and 30.5%, respectively. Malignant transformation rate of nondysplastic laryngeal lesions was 4.5%. Moderately and severely dysplastic lesions had significantly higher odds of malignant transformation compared with mildly dysplastic lesions (moderate: odds ratio [OR], 2.90 [95% CI, 2.06-4.09]; I2 = 0%; severe: OR, 3.42 [95% CI, 2.11-5.52]; I2 = 40%). Lesions without dysplasia had a significantly lower odds of malignant transformation compared with lesions with mild dysplasia (OR, 0.48; 95% CI, 0.28-0.81; I2 = 0%). The overall mean time to malignant transformation was 28.8 months (range, 22.0-35.6 months) for all dysplasia grades. CONCLUSION AND RELEVANCE: This systematic review and meta-analysis found that the rate of malignant transformation increased with the grade of laryngeal dysplasia. Moderately dysplastic lesions were more likely to undergo malignant degeneration compared with mildly dysplastic lesions.

来源:JAMA Otolaryngol Head Neck Surg,查看原文。版权归原作者所有。

引用

  1. Horton G, Philteos J, Lin RJ, et al. Malignant Transformation of Dysplastic Vocal Fold Lesions: A Systematic Review and Meta-Analysis. JAMA Otolaryngol Head Neck Surg. 2024. PMID: 38753339. doi:10.1001/jamaoto.2024.1008

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。